H9 CBFA2T3-GLIS2, H9 ETO2-GLIS2
WAe009-A-40
General#
Cell Line |
|
| hPSCreg Name | WAe009-A-40 |
| Alternative name(s) |
H9 CBFA2T3-GLIS2, H9 ETO2-GLIS2
|
| Cell line type | Human embryonic stem cell (hESC) |
| Last update | 15th June 2020 |
| User feedback | |
Provider |
|
| Generator | Centre for Genomics and Oncological Research (GENYO) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA7124963 |
| CLO | CLO_0102927 |
| Cellosaurus | CVCL_WM07 |
| Wikidata | Q93937305 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
Donor Information#
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
| Family history | NO |
| Is the medical history available upon request? | NO |
| Is clinical information available? | NO |
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA7768918 |
Ethics#
Also have a look at the ethics information for the parental line
WAe009-A
.
hESC Derivation#
|
The source cell information can be found in the parental cell line
WAe009-A.
|
Culture Conditions#
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| O2 Concentration | 20 % |
| CO2 Concentration | 5 % |
| Medium |
Essential 8™
|
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation#
No characterisation data could be found for this subclone. Please open parental cell line WAe009-AGenotyping#
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification#
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.